58 results
Page 2 of 3
8-K
EX-3.2
vts9djr
1 Aug 22
Quince Therapeutics Details Strategic Growth Plan with Launch of New Corporate Name
9:17am
424B5
ir9 lsgiok3s
19 May 22
Prospectus supplement for primary offering
4:44pm
8-K
EX-2.1
12i37
12 May 22
Entry into a Material Definitive Agreement
5:12pm
POS AM
39fkur1
4 Mar 22
Prospectus update (post-effective amendment)
4:04pm
POSASR
xxzmu4
7 Feb 22
Automatic shelf registration (post-effective amendment)
5:01pm
POSASR
EX-4.8
k92h opsd8
7 Feb 22
Automatic shelf registration (post-effective amendment)
5:01pm
424B5
hsld8drym2rydf4
23 Dec 21
Prospectus supplement for primary offering
5:24pm